Floatz logo

144 assets in Colorectal Carcinoma

Therapeutic assets addressing Colorectal Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Fpi-2053
Colorectal Carcinoma
AstraZenecaP1CC (43)
Fulvestrant
Colorectal Carcinoma
IDEAYA BiosciencesP1CC (43)
gad20-209-fsp, rp2d
Colorectal Carcinoma
National Cancer Institute (NCI)P1/2CC (43)
ide574
Colorectal Carcinoma
IDEAYA BiosciencesP1CC (43)
Ivonescimab
Colorectal Carcinoma
City of Hope Medical CenterP1CC (43)
Muzastotug
Colorectal Carcinoma
City of Hope Medical CenterP1CC (43)
Mva-209-Fsp, Rp2D
Colorectal Carcinoma
National Cancer Institute (NCI)P1/2CC (43)
Ribociclib
Colorectal Carcinoma
Novartis PharmaceuticalsP1/2CC (43)
s241656
Colorectal Carcinoma
Institut de Recherches Internationales ServierP1/2CC (43)
Talazoparib
Colorectal Carcinoma
Roswell Park Cancer InstituteP1CC (43)
Tegavivint
Colorectal Carcinoma
Children's Oncology GroupP1/2CC (43)
The-0504
Colorectal Carcinoma
Thena Biotech S.r.l.P1CC (43)
TIL
Colorectal Carcinoma
City of Hope Medical CenterP1CC (43)
Cis-Diamminedichloroplatinum Ii
Colorectal Carcinoma
City of Hope Medical CenterP1CC (42)
Ceralasertib
Colorectal Carcinoma
National Cancer Institute (NCI)P1CC (41)
Elimusertib
Colorectal Carcinoma
National Cancer Institute (NCI)P1CC (41)
Fermented Wheat Germ Extract
Colorectal Carcinoma
University of California, DavisP1CC (41)
Oatd-02
Colorectal Carcinoma
Molecure S.A.P1CC (41)
Arog4-01
Colorectal Carcinoma
Aromics TherapeuticsP1C (39)
Autologous, Engineered T Cells Targeting Tp53 R175H
Colorectal Carcinoma
AstraZenecaP1C (39)
AZD0240
Colorectal Carcinoma
AstraZenecaP1C (39)
azd0240: autologous, engineered t cells targeting kras g12d
Colorectal Carcinoma
AstraZenecaP1C (39)
bi 765049
Colorectal Carcinoma
Boehringer IngelheimP1C (39)
Fludeoxyglucose
Colorectal Carcinoma
Jonsson Comprehensive Cancer CenterP1C (39)
Janx008
Colorectal Carcinoma
Janux TherapeuticsP1C (39)
mgc028
Colorectal Carcinoma
MacroGenicsP1C (39)
ngm438
Colorectal Carcinoma
NGM Biopharmaceuticals, IncP1C (39)
ngm831
Colorectal Carcinoma
NGM Biopharmaceuticals, IncP1C (39)
NT-112
Colorectal Carcinoma
AstraZenecaP1C (39)
pf-07820435
Colorectal Carcinoma
PfizerP1C (39)
pf-07826390
Colorectal Carcinoma
PfizerP1C (39)
RC198
Colorectal Carcinoma
RemeGen Co., Ltd.P1C (39)
18f-αvβ6-bp
Colorectal Carcinoma
Julie L. Sutcliffe, Ph.DEarly P1C (36)
cdh17 car-t
Colorectal Carcinoma
Zhejiang UniversityEarly P1C (36)
Dordaviprone
Colorectal Carcinoma
National Cancer Institute (NCI)P1C (36)
Fast Laco-Stim Cdh17 Car-T
Colorectal Carcinoma
Zhejiang UniversityEarly P1C (36)
Incb099280
Colorectal Carcinoma
Incyte CorporationP1C (32)
Ropivacaine
Colorectal Carcinoma
Asklepios Kliniken Hamburg GmbHN/AD (30)
Soluble Fluorescein
Colorectal Carcinoma
Mayo ClinicN/AD (30)
Sasanlimab
Colorectal Carcinoma
PfizerP1D (28)
Cbx-12
Colorectal Carcinoma
National Cancer Institute (NCI)P2NR ()
kfa115
Colorectal Carcinoma
Novartis PharmaceuticalsP1NR ()
spn01 for
Colorectal Carcinoma
Beijing SonoPhotoNano Medical Technology Co., Ltd.P1NR ()
Thymosin Alpha 1
Colorectal Carcinoma
Fudan UniversityP3NR ()
Showing 101 to 144 of 144 assets
PreviousPage 3 of 3Next